LoongCrystal®PR Type Intraocular Lens Receives the First Approval through NMPA’s Innovative Device Approval Channel in 2025
LoongCrystal®PR Type intraocular lens (IOL), developed by Eyebright Medical, has been approved for marketing by the National Medical Products Administration (NMPA) on January 6, 2025....